FDA

News

Merck pulls Keytruda's FDA nod for third-line stomach cancer

Merck & Co will voluntarily withdraw a US marketing approval for cancer immunotherapy blockbuster Keytruda in gastric cancer, after studies intended to confirm its efficacy in this sett

News

FDA gives Roche's Actemra emergency okay for severe COVID

Roche has been granted emergency approval by the FDA for its arthritis drug Actemra as a treatment for patients aged two or over who are hospitalised with severe COVOD-19 symptoms.

News

Roche eyes October decision by FDA for wet AMD implant

The FDA has started a review of a new implant version of Roche's ranibizumab therapy for wet age-related macular degeneration, that could offer patients with the sight-robbing disorder an a

News

Consumer group seeks resignation of top FDA staffers over Ad...

With the first patient set to receive Biogen's new Alzheimer's drug Aduhelm in Rhode Island today, US consumer advocacy organisation Public Citizen is deeply unhappy about the FDA's approva

News

Novavax unveils phase 3 COVID jab data, but has it missed th...

The top-line phase 3 data for Novavax' COVID-19 vaccine look good, with a 90% overall efficacy rate, but a dip in its share price indicates investors fear it could be too late for the progr

News

J&J must ditch 60m COVID jabs made at US plant, but 10m are ...

The failings at a Baltimore, US factory making Johnson & Johnson's COVID-19 vaccine mean that millions of doses of the shot will have to be jettisoned, according to an FDA update.

Merck pulls Keytruda's FDA nod for third-line stomach cancer

FDA gives Roche's Actemra emergency okay for severe COVID

Roche eyes October decision by FDA for wet AMD implant

Consumer group seeks resignation of top FDA staffers over Ad...

Novavax unveils phase 3 COVID jab data, but has it missed th...

J&J must ditch 60m COVID jabs made at US plant, but 10m are ...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

FDA

Editor's Picks